vs

Side-by-side financial comparison of enCore Energy Corp. (EU) and EXAGEN INC. (XGN). Click either name above to swap in a different company.

EXAGEN INC. is the larger business by last-quarter revenue ($16.6M vs $12.4M, roughly 1.3× enCore Energy Corp.). EXAGEN INC. runs the higher net margin — -28.1% vs -173.9%, a 145.8% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-3.1M).

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

Exagen Inc. is a clinical diagnostics company specializing in developing, manufacturing, and commercializing proprietary testing solutions for autoimmune, rheumatic, and related chronic diseases. It mainly operates in the U.S. market, serving healthcare providers and patients to support accurate disease diagnosis and treatment monitoring.

EU vs XGN — Head-to-Head

Bigger by revenue
XGN
XGN
1.3× larger
XGN
$16.6M
$12.4M
EU
Higher net margin
XGN
XGN
145.8% more per $
XGN
-28.1%
-173.9%
EU
More free cash flow
EU
EU
$10.2M more FCF
EU
$7.2M
$-3.1M
XGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EU
EU
XGN
XGN
Revenue
$12.4M
$16.6M
Net Profit
$-21.5M
$-4.7M
Gross Margin
37.9%
55.4%
Operating Margin
-135.9%
-29.9%
Net Margin
-173.9%
-28.1%
Revenue YoY
21.8%
Net Profit YoY
-24.2%
EPS (diluted)
$-0.11
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EU
EU
XGN
XGN
Q4 25
$12.4M
$16.6M
Q3 25
$8.9M
$17.2M
Q2 25
$3.7M
$17.2M
Q1 25
$18.2M
$15.5M
Q4 24
$13.7M
Q3 24
$12.5M
Q2 24
$15.1M
Q1 24
$14.4M
Net Profit
EU
EU
XGN
XGN
Q4 25
$-21.5M
$-4.7M
Q3 25
$-4.8M
$-7.1M
Q2 25
$-6.3M
$-4.4M
Q1 25
$-24.2M
$-3.8M
Q4 24
$-3.8M
Q3 24
$-5.0M
Q2 24
$-3.0M
Q1 24
$-3.4M
Gross Margin
EU
EU
XGN
XGN
Q4 25
37.9%
55.4%
Q3 25
43.8%
58.4%
Q2 25
30.8%
60.4%
Q1 25
-0.1%
58.9%
Q4 24
62.1%
Q3 24
55.8%
Q2 24
60.1%
Q1 24
59.6%
Operating Margin
EU
EU
XGN
XGN
Q4 25
-135.9%
-29.9%
Q3 25
-158.2%
-18.0%
Q2 25
-526.1%
-15.3%
Q1 25
-85.7%
-21.7%
Q4 24
-24.8%
Q3 24
-37.3%
Q2 24
-17.2%
Q1 24
-20.8%
Net Margin
EU
EU
XGN
XGN
Q4 25
-173.9%
-28.1%
Q3 25
-53.7%
-41.1%
Q2 25
-172.7%
-25.8%
Q1 25
-132.9%
-24.2%
Q4 24
-27.5%
Q3 24
-40.2%
Q2 24
-19.7%
Q1 24
-23.3%
EPS (diluted)
EU
EU
XGN
XGN
Q4 25
$-0.11
$-0.21
Q3 25
$-0.03
$-0.31
Q2 25
$-0.03
$-0.21
Q1 25
$-0.13
$-0.20
Q4 24
$-0.20
Q3 24
$-0.28
Q2 24
$-0.16
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EU
EU
XGN
XGN
Cash + ST InvestmentsLiquidity on hand
$52.4M
$32.2M
Total DebtLower is stronger
$110.0M
$22.9M
Stockholders' EquityBook value
$229.2M
$17.4M
Total Assets
$430.4M
$58.0M
Debt / EquityLower = less leverage
0.48×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EU
EU
XGN
XGN
Q4 25
$52.4M
$32.2M
Q3 25
$91.9M
$35.7M
Q2 25
$26.9M
$30.0M
Q1 25
$29.7M
$11.2M
Q4 24
$22.0M
Q3 24
$22.0M
Q2 24
$24.5M
Q1 24
$27.3M
Total Debt
EU
EU
XGN
XGN
Q4 25
$110.0M
$22.9M
Q3 25
$109.3M
$22.9M
Q2 25
$23.0M
Q1 25
$20.9M
Q4 24
$20.2M
Q3 24
$20.3M
Q2 24
$20.3M
Q1 24
$19.5M
Stockholders' Equity
EU
EU
XGN
XGN
Q4 25
$229.2M
$17.4M
Q3 25
$248.6M
$18.1M
Q2 25
$264.7M
$21.0M
Q1 25
$267.9M
$6.4M
Q4 24
$9.5M
Q3 24
$12.9M
Q2 24
$17.6M
Q1 24
$20.0M
Total Assets
EU
EU
XGN
XGN
Q4 25
$430.4M
$58.0M
Q3 25
$441.9M
$62.8M
Q2 25
$359.4M
$58.8M
Q1 25
$362.6M
$40.3M
Q4 24
$44.7M
Q3 24
$43.6M
Q2 24
$49.3M
Q1 24
$50.8M
Debt / Equity
EU
EU
XGN
XGN
Q4 25
0.48×
1.31×
Q3 25
0.44×
1.26×
Q2 25
1.09×
Q1 25
3.27×
Q4 24
2.12×
Q3 24
1.57×
Q2 24
1.15×
Q1 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EU
EU
XGN
XGN
Operating Cash FlowLast quarter
$12.9M
$-3.0M
Free Cash FlowOCF − Capex
$7.2M
$-3.1M
FCF MarginFCF / Revenue
57.8%
-18.4%
Capex IntensityCapex / Revenue
46.7%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.0M
$-14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EU
EU
XGN
XGN
Q4 25
$12.9M
$-3.0M
Q3 25
$-20.3M
$2.9M
Q2 25
$-9.9M
$-2.9M
Q1 25
$-7.7M
$-10.7M
Q4 24
$363.0K
Q3 24
$-2.2M
Q2 24
$-2.4M
Q1 24
$-9.0M
Free Cash Flow
EU
EU
XGN
XGN
Q4 25
$7.2M
$-3.1M
Q3 25
$-26.3M
$2.7M
Q2 25
$-14.1M
$-3.1M
Q1 25
$-11.7M
$-10.8M
Q4 24
$217.0K
Q3 24
$-2.3M
Q2 24
$-2.6M
Q1 24
$-9.1M
FCF Margin
EU
EU
XGN
XGN
Q4 25
57.8%
-18.4%
Q3 25
-296.6%
15.5%
Q2 25
-385.2%
-18.0%
Q1 25
-64.1%
-69.6%
Q4 24
1.6%
Q3 24
-18.6%
Q2 24
-17.0%
Q1 24
-63.3%
Capex Intensity
EU
EU
XGN
XGN
Q4 25
46.7%
0.3%
Q3 25
68.0%
1.6%
Q2 25
115.1%
1.2%
Q1 25
21.7%
0.7%
Q4 24
1.1%
Q3 24
1.2%
Q2 24
0.9%
Q1 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EU
EU

Segment breakdown not available.

XGN
XGN

Commercial$9.3M56%
Government1$4.3M26%
Client Direct Bill$2.9M18%

Related Comparisons